Platelets primarily mediate hemostasis and thrombosis, whereas leukocytes are responsible for immune responses. Since platelets interact with leukocytes at the site of vascular injury, thrombosis and vascular inflammation are closely intertwined and occur consecutively. Recent studies using real-time imaging technology demonstrated that platelet-neutrophil interactions on the activated endothelium are an important determinant of microvascular occlusion during thromboinflammatory disease in which inflammation is coupled to thrombosis. Although the major receptors and counter receptors have been identified, it remains poorly understood how heterotypic platelet-neutrophil interactions are regulated under disease conditions. This review discusses our current understanding of the regulatory mechanisms of platelet-neutrophil interactions in thromboinflammatory disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480154 | PMC |
| http://dx.doi.org/10.1007/s00018-015-1845-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aerosol inhalation of rhIL-10 improves acute lung injury in mice by affecting pulmonary neutrophil phenotypes through neutrophil-platelet aggregates.
Int Immunopharmacol
January 2025
School of Basic Medicine, Qingdao University, Qingdao, China. Electronic address:
This study investigates the therapeutic effects of recombinant human IL-10 (rhIL-10) administered via aerosol inhalation in acute lung injury (ALI), with a particular focus on neutrophils. It explores how rhIL-10, in the presence of platelets, modulates neutrophil polarization to ameliorate acute lung injury. Initially, the ALI model established in mice demonstrated that aerosol inhalation of rhIL-10 significantly mitigated the cytokine storm in the lungs, reduced pulmonary edema, and alleviated histopathological damage to lung tissue.
View Article and Find Full Text PDFPlatelet-neutrophil aggregate formation induces NLRP3 inflammasome activation in vaccine-induced thrombotic thrombocytopenia.
J Thromb Haemost
December 2024
Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address:
Background: Although rare, vaccine-induced thrombotic thrombocytopenia (VITT) following adenoviral vector COVID-19 vaccination is a concerning and often severe adverse effect of vaccination. The generation of high antiplatelet factor 4 antibody titers promotes the formation of immune complexes capable of activating platelets and neutrophils through FcγRIIa.
Objectives: Given that platelet-leukocyte aggregate formation and inflammasome activation are common features of thromboinflammatory diseases, we aimed to evaluate if these are also features of VITT.
Platelet-Leukocyte Aggregate and Interleukin-6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case-Control Study.
Health Sci Rep
December 2024
HSC Research Center - Department of Hematology and Blood Banking School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.
Background And Aims: Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS. The interaction between cytokines and leukocytes in the presence of platelets results in platelet-leukocyte aggregate (PLA).
View Article and Find Full Text PDFIncreased Circulating Extracellular Superoxide Dismutase Attenuates Platelet-Neutrophil Interactions.
Am J Respir Cell Mol Biol
November 2024
University of Colorado - Anschutz Medical Campus, Aurora, United States.
Article Synopsis
- Acute respiratory distress syndrome (ARDS) is a severe condition that leads to high rates of ICU admissions and significant mortality, largely due to inflammation and oxidative stress, with few treatment options available.
- Research using transgenic mice with a specific mutation in the antioxidant enzyme extracellular superoxide dismutase (EC-SOD) suggests that this mutation helps protect against pneumonia and lung injury by reducing inflammation and neutrophil recruitment.
- The study shows that mice with the R213G variant of EC-SOD experience lower platelet activation and neutrophil influx during pneumonia, and treatment with an SOD mimetic further protects against these inflammatory responses.
Critical role for platelet Ral GTPases in regulating venous thrombosis in mice.
J Thromb Haemost
January 2025
School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom. Electronic address:
Background: Deep vein thrombosis is a major cause of morbidity and mortality globally. While its pathophysiology is complex, increasing evidence suggests a more prominent role for platelets than previously suspected. Genetic deletion of Ral GTPases, RalA and RalB, conditionally in mouse platelets (RalAB double knockout [DKO]), results in a near complete defect in P-selectin externalization upon activation, while other platelet activation responses and arterial thrombosis are preserved.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!